secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001213900-24-020181
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics receives 180-day Nasdaq extension to Sept 3, 2024 to meet $1 bid price rule
--------------------------------------------------------------------------------

- Nasdaq granted a 180-day extension until September 3, 2024 to regain minimum $1.00 closing bid price.
- Compliance requires $1.00 bid price for at least 10 consecutive business days; can be extended up to 20 days.
- Non-compliance was first disclosed on September 6, 2023; stock continues trading on Nasdaq under CVKD.
- Company may consider a reverse stock split if it cannot meet the price requirement by the deadline.
- If compliance not regained by Sept 3, 2024, Nasdaq will delist; company could appeal to hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024020181/0001213900-24-020181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024020181/ea0201254-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-020181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer